Tomudex, (now a trademark of Hospira) (raltitrexed)
Please note: Tomudex is now a trademark of Hospira. It continues to be produced and distributed by AstraZeneca in certain markets on Hospira's behalf.
Tomudex (raltitrexed) is an injectable cytotoxic agent for advanced colorectal cancer. It was developed as part of a collaboration with the Institute for Cancer Research in the UK and the British Technology Group.